Published in AIDS Weekly, April 28th, 1997
The paper, "Effect of immunization with an inactivated gp120 depleted HIV-1 immunogen (Remune) on beta chemokine and cytokine production in subjects with HIV-1 infection" (JAIDS, April 1, 1997), is the first published report of an immune-based therapy for HIV infection increasing the production of chemokines and other potent antiviral factors.
It describes an open-label trial of 15 subjects, and suggests that immune cells of individuals immunized with Remune significantly increased their capacity to produce chemokines in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-04-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.